Cost effectiveness and projected national impact of colorectal cancer screening in France

Cristiano Spada, Guido Costamagna, Cesare Hassan, R. Benamouzig, T. Ponchon, J. C. Saurin

Risultato della ricerca: Contributo in rivistaArticolo in rivista

46 Citazioni (Scopus)

Abstract

Colorectal cancer (CRC) is a major cause of morbidity and mortality in France. Only scanty data on cost-effectiveness of CRC screening in Europe are available, generating uncertainty over its efficiency. Although immunochemical fecal tests (FIT) and guaiac-based fecal occult blood tests (g-FOBT) have been shown to be cost-effective in France, cost-effectiveness of endoscopic screening has not yet been addressed.
Lingua originaleEnglish
pagine (da-a)780-793
Numero di pagine14
RivistaEndoscopy
Volume43
DOI
Stato di pubblicazionePubblicato - 2011

Keywords

  • Capsule Endoscopy
  • Colonoscopy
  • Colorectal Neoplasms
  • Computer Simulation
  • Cost-Benefit Analysis
  • France
  • Humans
  • Markov Chains
  • Mass Screening
  • Occult Blood
  • Sigmoidoscopy

Fingerprint

Entra nei temi di ricerca di 'Cost effectiveness and projected national impact of colorectal cancer screening in France'. Insieme formano una fingerprint unica.

Cita questo